CPDA-1 209 mg/70mL (Anticoagulant Citrate Phosphate Dextrose Adenine SOLUTION) 209 mg/70mL

CPDA-1 209 mg/70mL is an anticoagulant solution used to preserve blood components. This intravenous solution contains citrate, phosphate, dextrose, and adenine, designed for medical applications. Ideal for maintaining blood quality during storage.

Strength

209 mg/70mL

Pack Size

70 mL in 1 BAG (0942-6326-04)

Manufacturer / TM Owner

Fenwal, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

CPDA-1 209 mg/70mL is primarily used in medical settings to preserve blood and its components. This solution helps prevent clotting and maintains the integrity of blood cells during storage. It is commonly used in blood banks and hospitals for the preservation of whole blood and red blood cells. The solution's formulation supports the metabolic needs of blood cells, ensuring they remain viable for transfusion.

Side Effects

CPDA-1 209 mg/70mL works by inhibiting the clotting process and providing essential nutrients to blood cells. This helps maintain the quality and viability of blood components during storage. The solution's components, including citrate, phosphate, dextrose, and adenine, support cellular metabolism and prevent coagulation, ensuring the blood remains suitable for transfusion.

Precautions & Warnings

CPDA-1 209 mg/70mL should be handled with care to maintain sterility. It is important to follow proper storage guidelines to ensure the solution remains effective. The solution should be used under medical supervision and in accordance with established protocols. Always check the solution for any signs of contamination before use.

Avoid Interactions

CPDA-1 209 mg/70mL may interact with certain medications or substances. It is important to consult with a healthcare professional before using this solution in conjunction with other treatments. The solution's components may affect the efficacy of other medications, so it is crucial to consider potential interactions.

Frequently Asked Questions

CPDA-1 209 mg/70mL is used to preserve blood components by preventing clotting and maintaining cell viability during storage.

CPDA-1 209 mg/70mL should be stored according to the manufacturer's guidelines to ensure its effectiveness and sterility.

The main components of CPDA-1 209 mg/70mL include citrate, phosphate, dextrose, and adenine, which work together to preserve blood cells.

Potential interactions should be discussed with a healthcare professional before using CPDA-1 209 mg/70mL with other medications.

CPDA-1 209 mg/70mL is generally suitable for preserving all blood types, but specific protocols should be followed as directed by medical professionals.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.